Dehydroandrographolide targets CD300f and negatively regulated MRGPRX2‐induced pseudo‐allergic reaction

Abstract

Mas-related G protein-coupled receptor X2 (MRGPRX2) mediates mast cells (MCs) activation, which is a key target for the treatment of allergic diseases. However, there are few drugs targeting MRGPRX2. Leukocyte mono-immunoglobulin-like receptor 3 (CD300f) is a negative regulator of FcεRΙ-mediated MC activation. However, the regulatory effect of CD300f on MRGPRX2 remains unclear. Dehydroandrographolide (DA) is a main contributor of Andrographis paniculata (Burm.f.) Nees (family: Acanthaceae) have been shown to inhibit type I hypersensitivity. The aim of this study was to determine whether DA negatively regulated MRGPRX2-mediated MC activation via CD300f and showed therapeutic effect on pseudo-allergic reactions. Mouse allergic models and MC degranulation were detected in vivo and in vitro, and inflammatory mediators were detected. siRNA interference and Biacore were used to verify the target. DA inhibited pseudo-allergic reactions by reducing vasodilation and serum cytokine levels in mice and inhibited MRGPRX2-mediated MC activation. The regulatory effect of DA was significantly decreased after the knockdown of CD300f expression. Moreover, DA upregulated the phosphorylation level of Src homology region 2 domain-containing phosphatase (SHP)-1 and SHP-2, which are key kinases in the negative regulatory signaling pathways associated with CD300f. In conclusion, DA negatively regulates MRGPRX2-mediated MC activation via CD300f to inhibit pseudo-allergic reactions.

MRGPRX2 signaling involves the Lysyl-tRNA synthetase and MITF pathway

“…Most of these exogenous ligands are the molecular basis of MRGPRX2-dependent adverse drug reactions ( 7 , 8 ). Several molecules, such as natural compounds, cytokines, peptides, and DNA aptamers, have been described to prevent MRGPRX2-mediated pseudo-allergic responses and inflammation ( 9 – 11 ).…”

The effects and mechanisms of the anti-COVID-19 traditional Chinese medicine, Dehydroandrographolide from Andrographis paniculata (Burm.f.) Wall, on acute lung injury by the inhibition of NLRP3-mediated pyroptosis

“…Wall is a common variety of traditional Chinese medicine (TCM) ( Che et al, 2019 ). It is mainly used for the treatment of upper respiratory tract infection, bronchial asthma, viral pneumonia and diarrhea ( Che et al, 2022 ). Dehydroandrographolide (Deh, Andrographis paniculata (Burm.f.)…”

The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network pharmacology and bioinformatics

“…[4,5] Dehydroandrographolide is a diterpene lactone compound extracted from andrographis. Numerous studies have shown that dehydroandrographolide (DA) has anti-inflammatory, [6,7] anti-allergy, [8,9] antiviral, [10] hepatobiliary protection, [11] and other drug activities. In recent years, it has been found that DA shows effective anti-cancer activity in various cancers, mainly by inhibiting proliferation, promoting apoptosis, and reducing the migration and invasion of cancer cells.…”